Clinical Trials on Muscular Dystrophies in New Zealand

Total 5198 results

Flanders Medical Research Program

Completed

PREVENT: Promus BTK (PREVENT)

Peripheral Arterial Disease

Belgium, Germany, New Zealand
Endologix

Completed

Feasibility and Safety Study of the Endologix Fenestrated Stent Graft System

Abdominal Aortic Aneurysm

United States, New Zealand, Chile, France, Netherlands, United Kingdom
Medtronic Endovascular
Medtronic - MITG; Meditrial Europe Ltd.

Completed

Rapid Renal Sympathetic Denervation for Resistant Hypertension (RAPID)

Hypertension, Resistant to Conventional Therapy

Netherlands, Germany, Belgium, Italy, Luxembourg, New Zealand
Boston Scientific Corporation

Completed

Stenting of the Superficial Femoral and/or Proximal Popliteal Artery Project (MAJESTIC)

Atherosclerosis of Native Arteries of the Extremities

New Zealand, Germany, Belgium, Australia, Austria
Elixir Medical Corporation

Completed

Elixir Medical Clinical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - The DESolve Nx Trial

Coronary Artery Disease

New Zealand, Belgium, Germany, Poland, Denmark, Brazil
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque (PREVENT)

Coronary Artery Disease | Plaque, Atherosclerotic

Korea, Republic of, Taiwan, United States, Japan, New Zealand
Abbott Medical Devices

Completed

ABSORB Clinical Investigation, Cohort B (ABSORB B)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Netherlands, Poland, France, Denmark, Australia, Switzerland, Belgium
The George Institute
National Health and Medical Research Council, Australia

Completed

Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage

Intracranial Hemorrhages | Cerebral Hemorrhage | CVA (Cerebrovascular Accident)

Australia, New Zealand, China
Second Sight Medical Products
National Eye Institute (NEI)

Completed

Argus® II Retinal Stimulation System Feasibility Protocol

Retinitis Pigmentosa

United States, United Kingdom, France, Mexico, Switzerland
4D Molecular Therapeutics

Active, not recruiting

4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)

X-Linked Retinitis Pigmentosa

United States
Santen Inc.
ActualEyes Inc.

Recruiting

A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD) (PHANTOM)

Fuchs Endothelial Corneal Dystrophy

United States
TriReme Medical, LLC

Active, not recruiting

The Chocolate Touch Study

Ischemia | Intermittent Claudication | Peripheral Artery Disease (PAD)

New Zealand, United States, Austria, Germany
Neurotech Pharmaceuticals

Completed

A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa

Retinitis Pigmentosa

United States
Boston Scientific Corporation

Completed

A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) (PLATINUM QCA)

Coronary Artery Disease | Atherosclerosis

Australia, New Zealand, Malaysia, Singapore
Richard Barohn, MD

Completed

Effectiveness of Mexiletine for Treating People With Non-Dystrophic Myotonia

Non-Dystrophic Myotonia | Myotonia

United States, Canada, Italy, United Kingdom
Kowa Research Institute, Inc.

Completed

Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis

Fuchs' Endothelial Corneal Dystrophy

United States, Australia, Germany, Spain, Denmark
Vitreous -Retina- Macula Consultants of New York
Genentech, Inc.

Completed

Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema

Retinal Vein Occlusion

United States
The New York Eye & Ear Infirmary

Unknown

Post Intravitreal Injection Topical NSAID vs. Patching

Diabetic Macular Edema | Retinal Vein Occlusion | Neovascular Age-related Macular Degeneration

United States
Dart NeuroScience, LLC

Terminated

DNS-3379 vs. Placebo in Stroke Rehabilitation (SPIRIT)

Ischemic Stroke

Australia, New Zealand
Second Sight Medical Products

Terminated

New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System

Retinitis Pigmentosa

United States
Neuroscience Trials Australia
National Health and Medical Research Council, Australia; Monash University

Active, not recruiting

Trial of EXenatide in Acute Ischaemic Stroke (TEXAIS)

Acute Ischemic Stroke

Australia, Finland, New Zealand
Columbia University
Ludwig-Maximilians - University of Munich; Moorfields Eye Hospital NHS Foundation... and other collaborators

Recruiting

CNGB1 and Allied Disorders

Retinitis Pigmentosa Associated With CNGB1 Mutations

United States, France, Germany, United Kingdom
Gilead Sciences

Completed

Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation

Hepatitis C | Cirrhosis | Portal Hypertension | With or Without Liver Decompensation

United States, Spain, New Zealand, Australia, France
Rigshospitalet, Denmark

Completed

Study of the Natural Variation in Strokevolume

Stroke Volume Variation

Denmark
Neurotech Pharmaceuticals

Completed

A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa

Retinitis Pigmentosa

United States
Allergan

Completed

Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)

Choroidal Neovascularization | Age-Related Maculopathy

France, Korea, Republic of, New Zealand, Italy, Israel, United States, Portugal, Australia, United Kingdom
Lions Eye Institute, Perth, Western Australia
Allergan; Lions Outback Vision

Completed

Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMO (OASIS)

Diabetic Retinopathy | Diabetic Macular Edema

Australia
Vascutek Ltd.

Terminated

Vascutek Anaconda™ Abdominal Aortic Aneurysm (AAA) Post-Market Surveillance Registry

Abdominal Aortic Aneurysm

United Kingdom, Australia, New Zealand, Germany, France, Italy, Spain
Boston Scientific Corporation

Completed

A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s) (EVOLVE48)

Coronary Artery Disease

United States, United Kingdom, New Zealand, Latvia
C. R. Bard

Completed

BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease (BOLSTER)

Peripheral Vascular Disease | Peripheral Artery Disease | Arterial Occlusive Disease

United States, Germany, New Zealand
Institute for Molecular Medicine

Suspended

Membrane Lipid Replacement in Fibromyalgia

Fibromyalgia

United States
Starr Muscle
Ohr Pharmaceutical Inc.

Withdrawn

Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME)

Diabetic Retinopathy

United States
University of Canterbury
Tan Tock Seng Hospital; University of Toronto; Fremantle Hospital and Health... and other collaborators

Completed

Outcomes of Swallowing Rehabilitation After Stroke

Stroke | Dysphagia | Cerebrovascular Accident

Singapore, Canada, Australia, New Zealand
University of Sydney
Genentech, Inc.

Recruiting

A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients. (RESTORE-MI)

STEMI | Elevated IMR (>32)

Australia, New Zealand
Neuroscience Trials Australia
The Florey Institute of Neuroscience and Mental Health

Completed

Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke (EXTEND-IA TNK)

Ischemic Stroke

Australia, New Zealand
Second Sight Medical Products

Terminated

Argus® II Retinal Prosthesis System Post-Market Surveillance Study

Retinitis Pigmentosa | Outer Retinal Degeneration

Germany, Italy
W.L.Gore & Associates

Completed

A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries. (VBXFLEX)

Peripheral Arterial Disease

New Zealand, United States
Kowa Research Institute, Inc.

Recruiting

A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

Fuchs Endothelial Corneal Dystrophy

United States, Germany, Spain, Canada, United Kingdom, Denmark
Trefoil Therapeutics, Inc.

Completed

A Phase 1/ Phase 2 Study of TTHX1114(NM141) (INTREPID)

Endothelial Dysfunction | Corneal Endothelial Dystrophy | Pseudophakic Bullous Keratopathy | Fuchs Endothelial Corneal Dystrophy

United States
Al-Azhar University

Completed

Formulated PSTA Injection Versus PATA Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein Occlusions

Macula Edema

Egypt
Long Island Vitreoretinal Consultants

Completed

Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)

Central Retinal Vein Occlusion | Macular Edema

United States
Kona Medical Inc.

Unknown

Sham Controlled Study of Renal Denervation for Subjects With Uncontrolled Hypertension (WAVE_IV)

Hypertension

Germany, United Kingdom, Poland, Australia, Austria, Colombia, Czech Republic, New Zealand
Medtronic Endovascular

Completed

IN.PACT™ AV Access IDE Study

Fistula | Arteriovenous Fistula | Arteriovenous Fistula Stenosis | Arteriovenous Fistula Occlusion

New Zealand, United States, Japan
Antonios Likourezos

Withdrawn

Radial Artery Spasm Leading to Occlusion in Patients Undergoing Coronary Angiogram Via Radial Access

Arterial Occlusion | Arterial Spasm

United States
The New York Eye & Ear Infirmary

Unknown

Age-related Macular Degeneration (AMD) and Cardiovascular Disease

Cardiovascular Diseases | Coronary Artery Disease | Age-related Macular Degeneration

United States
University of Sydney

Recruiting

Near-Infrared Light Photobiomodulation Treatment for Retinal Vein Occlusion Macular Oedema (NIRVO)

Retinal Vein Occlusion | Macula Edema

Australia
AO Clinical Investigation and Publishing Documentation

Recruiting

Alloplastic Total Temporomandibular Joint (TMJ) Replacement Registry

Temporomandibular Joint Disorders

Sweden, Germany, Switzerland, Poland, Serbia, Brazil, Colombia, India, Netherlands, New Zealand, Russian Federation, Spain, Pakistan, South Africa
Columbia University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Oxidative Capacity and Exercise Tolerance in Ambulatory SMA

Spinal Muscular Atrophy Type 3 | Mitochondrial Myopathy

United States
Kowa Research Institute, Inc.

Recruiting

A Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

Fuchs Endothelial Corneal Dystrophy

United States, United Kingdom, Spain, Germany, Canada, Denmark
Invex Therapeutics Ltd.
Premier Research Group plc; University Hospitals Birmingham Neuro Ophthalmology... and other collaborators

Terminated

A Trial to Determine the Efficacy and Safety of Presendin in IIH (IIH EVOLVE)

Idiopathic Intracranial Hypertension

Israel, Germany, Australia, United States, United Kingdom, New Zealand

Clinical Trials on Muscular Dystrophies in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations